Clinical Trial

Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

Study acronym: IRIS SynergyXD
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-09-06; most recent amendment 2025-12-21.
Status change: Not Yet Recruiting → Recruiting 2022-12-11
Trial Details
NCT Number NCT05044273
Lead Sponsor Jung-min Ahn
Collaborators: CardioVascular Research Foundation, Korea
Conditions Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases, Myocardial Ischemia, Coronary Disease
Enrollment 2,000 participants
Start Date 2022-09-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-29